3 excellent ASX growth shares named as buys

Analysts rate these ASX growth shares highly right now…

| More on:
3 asx shares to buy depicted by man holding up hand with 3 fingers up

Image source: Getty Images

There are a lot of growth shares for investors to choose from on the Australian share market. In order to narrow things down, I have picked out three that are highly rated by analysts.

Here鈥檚 what you need to know about these ASX growth shares:

Breville Group Ltd聽(ASX: BRG)

The first ASX growth share to look at is this leading appliance manufacturer. It has been growing at a solid rate for a number of years and continued this trend in FY 2021. In fact, the company鈥檚 growth accelerated and led to it outperforming its guidance. Breville reported a 24.7% increase in revenue to $1,187.7 million and a 39.6% jump in earnings before interest and tax (EBIT) to $136.4 million.

Morgans is a fan of the company. It currently has an add rating and $34.00 price target on its shares. The broker believes the company is capable of double digit, multi-year organic revenue growth.

IDP Education Ltd聽(ASX: IEL)

Another ASX growth share to look at is IDP Education. It is a provider of international student placement services and English language testing services. For obvious reasons, it was hit hard by the pandemic. However, the company has been tipped to win market share once the crisis passes and trading conditions return to normal. It has also boosted its future growth with a key acquisition in the lucrative India market.

Last week UBS retained its buy rating and lifted its price target on the company’s shares to $36.40. The broker believes IDP Education is well-placed for a big earnings recovery once the pandemic passes.

ResMed Inc.聽(ASX: RMD)

Another ASX growth share to look at is ResMed. It is a medical device company with a focus on the sleep treatment market. ResMed has been growing at a solid rate for over a decade. This has been underpinned by聽its industry-leading products, wide distribution, and successful acquisitions. Pleasingly, thanks to its significant market opportunity and the growing prevalence of sleep disorders, it has been tipped to continue this positive form long into the future.

Credit Suisse believes the company is well-positioned to grow at above-industry rates over the long term. Earlier this month the broker retained its outperform rating and lifted its price target to $44.00.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Idp Education Pty Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on 鈴革笍 Growth Investing